The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 17, 2026

Filed:

Feb. 26, 2021
Applicant:

Grail, Inc., Menlo Park, CA (US);

Inventors:

Collin Melton, Menlo Park, CA (US);

Earl Hubbell, Palo Alto, CA (US);

Oliver Claude Venn, San Francisco, CA (US);

Assignee:

GRAIL, Inc., Menlo Park, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G16B 40/20 (2019.01); C12Q 1/6886 (2018.01); G06F 18/2415 (2023.01); G16B 20/00 (2019.01); G16B 45/00 (2019.01);
U.S. Cl.
CPC ...
G16B 40/20 (2019.02); C12Q 1/6886 (2013.01); G06F 18/24155 (2023.01); G16B 20/00 (2019.02); G16B 45/00 (2019.02); C12Q 2600/154 (2013.01);
Abstract

Systems and methods of identifying methylation patterns discriminating or indicating a cancer condition are provided. First and second datasets are obtained. Each dataset comprises a plurality of fragment methylation patterns determined by methylation sequencing of nucleic acids obtained from a first or second set of subjects and comprising a methylation state of each CpG site in a corresponding plurality of CpG sites. Each plurality of subjects has a respective first or second state of the cancer condition. First and second interval maps are generated for each respective dataset, each comprising a plurality of nodes characterized by a start methylation site, an end methylation site, a representation of each different fragment methylation pattern and a count of fragments. The first and second interval maps are scanned for qualifying methylation patterns within a predetermined range of CpG sites, satisfying one or more selection criteria, thereby identifying methylation patterns discriminating a cancer condition.


Find Patent Forward Citations

Loading…